Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling

Abstract Background Ufm1-specific ligase 1 (Ufl1) and Ufm1-binding protein 1 (Ufbp1), as putative targets of ubiquitin-fold modifier 1 (Ufm1), have been implicated in several pathogenesis-related signaling pathways. However, little is known about their functional roles in liver disease. Methods Hepa...

Full description

Bibliographic Details
Main Authors: Fanghui Chen, Le Sheng, Tianci Zhou, Li Yan, Reid Loveless, Honglin Li, Yong Teng, Yafei Cai
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-023-02681-6
_version_ 1797831850318626816
author Fanghui Chen
Le Sheng
Tianci Zhou
Li Yan
Reid Loveless
Honglin Li
Yong Teng
Yafei Cai
author_facet Fanghui Chen
Le Sheng
Tianci Zhou
Li Yan
Reid Loveless
Honglin Li
Yong Teng
Yafei Cai
author_sort Fanghui Chen
collection DOAJ
description Abstract Background Ufm1-specific ligase 1 (Ufl1) and Ufm1-binding protein 1 (Ufbp1), as putative targets of ubiquitin-fold modifier 1 (Ufm1), have been implicated in several pathogenesis-related signaling pathways. However, little is known about their functional roles in liver disease. Methods Hepatocyte-specific Ufl1 Δ/Δhep and Ufbp1 Δ/Δhep mice were used to study their role in liver injury. Fatty liver disease and liver cancer were induced by high-fat diet (HFD) and diethylnitrosamine (DEN) administration, respectively. iTRAQ analysis was employed to screen for downstream targets affected by Ufbp1 deletion. Co-immunoprecipitation was used to determine the interactions between the Ufl1/Ufbp1 complex and the mTOR/GβL complex. Results Ufl1 Δ/Δhep or Ufbp1 Δ/Δhep mice exhibited hepatocyte apoptosis and mild steatosis at 2 months of age and hepatocellular ballooning, extensive fibrosis, and steatohepatitis at 6–8 months of age. More than 50% of Ufl1 Δ/Δhep and Ufbp1 Δ/Δhep mice developed spontaneous hepatocellular carcinoma (HCC) by 14 months of age. Moreover, Ufl1 Δ/Δhep and Ufbp1 Δ/Δhep mice were more susceptible to HFD-induced fatty liver and DEN-induced HCC. Mechanistically, the Ufl1/Ufbp1 complex directly interacts with the mTOR/GβL complex and attenuates mTORC1 activity. Ablation of Ufl1 or Ufbp1 in hepatocytes dissociates them from the mTOR/GβL complex and activates oncogenic mTOR signaling to drive HCC development. Conclusions These findings reveal the potential role of Ufl1 and Ufbp1 as gatekeepers to prevent liver fibrosis and subsequent steatohepatitis and HCC development by inhibiting the mTOR pathway.
first_indexed 2024-04-09T13:59:24Z
format Article
id doaj.art-e23daf3fac0a4d4b99326cc2fc373db7
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-04-09T13:59:24Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-e23daf3fac0a4d4b99326cc2fc373db72023-05-07T11:27:16ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662023-05-0142112110.1186/s13046-023-02681-6Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signalingFanghui Chen0Le Sheng1Tianci Zhou2Li Yan3Reid Loveless4Honglin Li5Yong Teng6Yafei Cai7College of Animal Science and Technology, Nanjing Agricultural UniversityCollege of Animal Science and Technology, Nanjing Agricultural UniversityCollege of Animal Science and Technology, Nanjing Agricultural UniversityDepartment of Radiation Oncology, Linyi People HospitalDepartment of Oral Biology and Diagnostic Sciences, Georgia Cancer Center, Augusta UniversityDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of MedicineCollege of Animal Science and Technology, Nanjing Agricultural UniversityAbstract Background Ufm1-specific ligase 1 (Ufl1) and Ufm1-binding protein 1 (Ufbp1), as putative targets of ubiquitin-fold modifier 1 (Ufm1), have been implicated in several pathogenesis-related signaling pathways. However, little is known about their functional roles in liver disease. Methods Hepatocyte-specific Ufl1 Δ/Δhep and Ufbp1 Δ/Δhep mice were used to study their role in liver injury. Fatty liver disease and liver cancer were induced by high-fat diet (HFD) and diethylnitrosamine (DEN) administration, respectively. iTRAQ analysis was employed to screen for downstream targets affected by Ufbp1 deletion. Co-immunoprecipitation was used to determine the interactions between the Ufl1/Ufbp1 complex and the mTOR/GβL complex. Results Ufl1 Δ/Δhep or Ufbp1 Δ/Δhep mice exhibited hepatocyte apoptosis and mild steatosis at 2 months of age and hepatocellular ballooning, extensive fibrosis, and steatohepatitis at 6–8 months of age. More than 50% of Ufl1 Δ/Δhep and Ufbp1 Δ/Δhep mice developed spontaneous hepatocellular carcinoma (HCC) by 14 months of age. Moreover, Ufl1 Δ/Δhep and Ufbp1 Δ/Δhep mice were more susceptible to HFD-induced fatty liver and DEN-induced HCC. Mechanistically, the Ufl1/Ufbp1 complex directly interacts with the mTOR/GβL complex and attenuates mTORC1 activity. Ablation of Ufl1 or Ufbp1 in hepatocytes dissociates them from the mTOR/GβL complex and activates oncogenic mTOR signaling to drive HCC development. Conclusions These findings reveal the potential role of Ufl1 and Ufbp1 as gatekeepers to prevent liver fibrosis and subsequent steatohepatitis and HCC development by inhibiting the mTOR pathway.https://doi.org/10.1186/s13046-023-02681-6Ufl1/Ufbp1mTORHepatic fibrosisFatty liverHCC
spellingShingle Fanghui Chen
Le Sheng
Tianci Zhou
Li Yan
Reid Loveless
Honglin Li
Yong Teng
Yafei Cai
Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling
Journal of Experimental & Clinical Cancer Research
Ufl1/Ufbp1
mTOR
Hepatic fibrosis
Fatty liver
HCC
title Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling
title_full Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling
title_fullStr Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling
title_full_unstemmed Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling
title_short Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling
title_sort loss of ufl1 ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mtor signaling
topic Ufl1/Ufbp1
mTOR
Hepatic fibrosis
Fatty liver
HCC
url https://doi.org/10.1186/s13046-023-02681-6
work_keys_str_mv AT fanghuichen lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling
AT lesheng lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling
AT tiancizhou lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling
AT liyan lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling
AT reidloveless lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling
AT honglinli lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling
AT yongteng lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling
AT yafeicai lossofufl1ufbp1inhepatocytespromotesliverpathologicaldamageandcarcinogenesisthroughactivatingmtorsignaling